BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

ALLIANCE FOR PHARMACY COMPOUNDING — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

ALLIANCE FOR PHARMACY COMPOUNDING

via HANCE SCARBOROUGH

2nd Quarter (Apr 1 - June 30) · 2026Posted Jul 17, 2026Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: ALLIANCE FOR PHARMACY COMPOUNDING
Description: Non-profit association promoting the practice of pharmacy compounding
Location: Texas · United States of America

Registrant

Firm: HANCE SCARBOROUGH
Description: Law Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

3 issues

Health Issues
Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Drug Shortages SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations
LobbyistsMICHAEL TOMBERLIN · THERESA REED · mr ROBERT DAVID PORE
Covered position (MICHAEL TOMBERLIN): Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep., Louie Gohmert
Covered position (THERESA REED): Leg. Director for Multiple Members
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Drug Shortages SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations
LobbyistsMICHAEL TOMBERLIN · THERESA REED · mr ROBERT DAVID PORE
Covered position (MICHAEL TOMBERLIN): Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert
Covered position (THERESA REED): Leg. Director for Multiple Members
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

Budget/Appropriations

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations

LobbyistsMICHAEL TOMBERLIN · THERESA REED · mr ROBERT DAVID PORE

Covered position (MICHAEL TOMBERLIN): COS for Rep. Chip Cravaack, COS for Rep. Louie Gohmert

Covered position (THERESA REED): Leg. Director for Multiple Members

TargetedSENATE · HOUSE OF REPRESENTATIVES